ID: ALA5273588

Max Phase: Preclinical

Molecular Formula: C18H12ClF6N3O3

Molecular Weight: 467.75

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1ccc(OC(F)(F)F)cc1)N1CCN(c2ccc(Cl)c(C(F)(F)F)c2)C1=O

Standard InChI:  InChI=1S/C18H12ClF6N3O3/c19-14-6-3-11(9-13(14)17(20,21)22)27-7-8-28(16(27)30)15(29)26-10-1-4-12(5-2-10)31-18(23,24)25/h1-6,9H,7-8H2,(H,26,29)

Standard InChI Key:  GYDNRSVARPMJDK-UHFFFAOYSA-N

Associated Targets(Human)

HeLa 62764 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HepG2 196354 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Staphylococcus epidermidis 22802 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 467.75Molecular Weight (Monoisotopic): 467.0471AlogP: 5.73#Rotatable Bonds: 3
Polar Surface Area: 61.88Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.84CX Basic pKa: CX LogP: 5.60CX LogD: 5.60
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.59Np Likeness Score: -1.78

References

1. Du X, Wang M, Hu X, Nie T, Zhu M, Zhang G, You X, Wang Y..  (2022)  Synthesis and biological evaluation of novel N, N'-diarylurea derivatives as potent antibacterial agents against MRSA.,  75  [PMID:36067930] [10.1016/j.bmcl.2022.128975]

Source